|Maine Medicine Weekly E-Update, January 18, 2022
FDA Recall: Metformin HCl Extended- Release Tablets USP, 750 mg by Viona Pharmaceuticals
Viona Pharmaceuticals is recalling twenty-three (23) lots of Metformin Hydrochloride Extended-Release Tablets USP, 750 mg because an Out of Specification (OOS) result observed for one lot of the product (M008132) “N-nitrosodimethylamine (NDMA).
The company issued a similar recall for the medicine in June 2021 for the same reason.< Previous Article | Next Article >
[ return to top ]
ensure delivery of Maine Medicine Weekly Update,
please add 'email@example.com' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details: http://www.commpartners.com/website/white-listing.htm
For more information or to contact us directly, please visit www.mainemed.com | ©